SI-BONE, Inc..
SIBN.US | Manufacture of medical and dental instruments and supplies
SI-BONE, Inc. is a medical device company that develops and commercializes minimally invasive surgical implants and instruments for the treatment of musculoskeletal disorders of the sacropelvic anatomy, primarily the sacroiliac (SI) joint. Their primary product is the iFuse Implant System, a minimal...Show More
Better Health for All
0
Insufficient evidence to determine a value score for SI-BONE, Inc. regarding Better Health for All. No articles or relevant information found. A neutral score of 0 is assigned.
Materiality Analysis: Company Summary (75-100 words): SI-BONE, Inc. is a medical device company specializing in minimally invasive surgical implant systems for musculoskeletal disorders of the sacropelvic anatomy. Their core products include the iFuse line of implants used in sacroiliac joint fusion and pelvic trauma treatment. They market these products through a direct sales force and third-party agents, primarily in the US and internationally. Recent product launches include iFuse-3D and iFuse TORQ, expanding their implant offerings. Their focus is on improving surgical outcomes for patients with specific joint and pelvic issues.
Peer Comparison (50-75 words): Compared to other medical device companies, SI-BONE's impact on "Better Health for All" is relatively focused. While many device companies address a wide range of conditions, SI-BONE targets a specific area. Their impact is likely comparable to other specialized orthopedic device manufacturers, with a similar potential for improving patient outcomes within their niche.
Materiality Assessment (1-2 clear sentences): The business model is fundamentally supportive of the "Better Health for All" value, with a medium level of materiality, as it directly addresses musculoskeletal disorders and aims to improve patient health outcomes through surgical interventions.
Detailed Rationale (150-200 words): SI-BONE's core business directly contributes to "Better Health for All" by providing medical devices designed to alleviate pain and improve function for individuals suffering from sacroiliac joint dysfunction and pelvic trauma. The company's minimally invasive surgical techniques can potentially reduce recovery times and improve patient quality of life compared to traditional surgical approaches. While their products are not preventative in nature, they address existing health issues and aim to restore functionality. The accessibility of these treatments is a consideration, as the cost of surgery and implants can be a barrier for some patients. However, the company's focus on improving surgical outcomes and addressing a specific medical need aligns with the value of promoting better health. The company's innovation in 3D-printed implants also suggests an investment in improving health outcomes.
Value Interaction Notes (if applicable, 25-50 words): The company's focus on surgical implants may present a tension with "Affordable Access," as the cost of these procedures can be significant. Balancing innovation with cost-effectiveness is important.
Scoring Boundary Flags (if applicable, 25-50 words): Scores significantly below the midpoint would be illogical, as the company's core business directly addresses a health need. A score below 3 would be inconsistent with their mission.
Fair Money & Economic Opportunity
0
SI-BONE, Inc. is a medical device company that develops and commercializes surgical implants and instruments.
1
The company does not offer lending, insurance, or deposit services to consumers, nor does it engage in financial activities that would directly impact consumer financial inclusion or economic opportunity as defined by the rubric.
2
Therefore, all KPIs related to financial products, services, and customer financial outcomes are not applicable. While SI-BONE provides product donations for indigent patients
3
and makes charitable grants to non-profit entities for purposes like indigent care, patient education, and public health,
4
these activities relate to medical product access and general philanthropy, not to financial inclusion or economic opportunity through financial services.
Fair Pay & Worker Respect
20
For Fiscal Year 2024, the CEO to median employee pay ratio was 39:1.
1
The company's voluntary employee turnover rate was approximately 8% in 2024.
2
Employee engagement, based on Glassdoor reviews, shows an overall rating of 4.1 out of 5 stars.
3
The company has not incurred any monetary losses from legal proceedings related to bribery, corruption, or false marketing claims.
4
SI-BONE has a Code of Business Conduct and Ethics, a Supplier Code of Conduct, and an Equal Employment Opportunity and Affirmative Action Policy that prohibit discrimination and harassment.
5
A compliance hotline is available for reporting concerns, and retaliation is prohibited.
6
All employees undergo annual training on ethics and compliance policies.
7
Fair Trade & Ethical Sourcing
0
SI-BONE's Supplier Code of Conduct prohibits forced labor and child labor, and no incidents were reported in 2023.
1
The company screens all third-party distributors and agents globally upon onboarding and regularly monitors them for potential risks.
2
Honest & Fair Business
-50
The company provides anonymous toll-free numbers and an online form for whistleblowers, but there is no evidence regarding independent investigation processes, training, or effectiveness metrics.
1
An anti-corruption policy is in place, including a Code of Conduct, policies for interactions with healthcare professionals, and an annual spending limit for California, but its scope regarding international operations or high-risk markets is not detailed.
2
The company adheres to HHS-OIG Guidance, the AdvaMed Code of Ethics, and California Health & Safety Code compliance, including an annual written declaration of compliance, but the extent of independent verification of these ethical claims is not specified.
3
Kind to Animals
-40
SI-BONE funds and is involved in studies that use animal testing.
1
A study funded by SI-BONE, published in 2024, used 8 adult sheep for in vivo evaluations of implants.
2
The experiments were performed under a project license granted by an Animal Care and Ethics Committee and in compliance with University institutional guidelines for animal care and use.
3
The company does not explicitly mention an animal testing policy in its Supplier Code of Conduct or sustainability report, and no specific data on animal welfare policies is available.
4
No War, No Weapons
0
SI-BONE, Inc. is a medical device company that develops and commercializes surgical implants and instruments for musculoskeletal disorders.
1
The provided articles consistently describe the company's core business as medical devices, specifically the iFuse Implant System for SI joint dysfunction. There is no evidence in the articles of the company engaging in arms manufacturing, military contracts, dual-use technology development, sales to embargoed regimes, peacebuilding investments, or any other activities related to the 'No War, No Weapons' value. Therefore, all relevant KPIs are scored as N/A, indicating no defense or arms-related activities in their core business or no exposure to weapons.
Planet-Friendly Business
-20
The company and its subsidiaries have complied with Environmental Laws, and there have been no outstanding citations, notices, or orders of non-compliance issued to the company or its subsidiaries.
1
The company also states that it has not incurred significant expenses relating to environmental compliance and does not expect to in the foreseeable future, as it outsources substantially all manufacturing.
2
Respect for Cultures & Communities
10
SI-BONE has no reported cultural appropriation incidents.
1
The company provides a whistleblower hotline for anonymous reporting of policy violations, available internally and externally on its website, with toll-free numbers for North America, Italy, Germany, United Kingdom, France, and Spain.
2
This suggests grievance mechanisms are available across a significant portion of its operational sites. The provision of toll-free numbers in multiple countries indicates basic language inclusivity in communication channels.
3
All employees are required to complete annual training on key ethics and compliance policies.
4
Safe & Smart Tech
-10
SI-BONE, Inc. disclosed a data breach on October 1, 2025, impacting approximately 955 Texas residents, with exposed data including names, Social Security numbers, and medical information.
1
The company engaged cybersecurity experts, sent notices, and offered credit monitoring.
2
The company has experienced breaches in the past.
3
It provides mandatory annual security and privacy awareness training to all employees with access to company email and devices, including phishing simulations.
4
Its privacy policy, last modified December 27, 2022, allows users to request access, correction, or deletion of personal information and to unsubscribe from communications.
5
The company retains personal information as long as necessary for collection purposes, including legal/reporting requirements, and may anonymize it for indefinite use in research/statistics.
6
SI-BONE complies with California Health & Safety Code §§ 119400-119402.
7
The company has signed EU Standard Contractual Clauses.
8
The company conducts audits and evaluations of its IT infrastructure, network architecture, and software applications to identify vulnerabilities, engaging third parties for penetration testing and independent audits.
9
Critical vulnerabilities are patched within 21-30 days on average.
10
The company integrates AI and machine learning technologies in its operations, acknowledging risks such as errors, bias, and data leaks, and notes that privacy laws may be incompatible with its AI use.
11
Zero Waste & Sustainable Products
0
No evidence available to assess SI-BONE, Inc. on Zero Waste & Sustainable Products.